Today on Medscape

Top Stories from Across Medicine
 
 

Top Medical News from Across Medscape

  • EMA Panel Likes Breast and Kidney Cancer DrugsThe Committee for Medicinal Products for Human Use recommended approval of ribociclib for advanced HER+/HER2- breast cancer and tivozanib for advanced renal cell carcinoma.
  • Hodgkin's Tx Intensity Can Be Spared With Negative PETPatients with advanced Hodgkin's lymphoma who show early metabolic response on FDG-PET scans can safely and effectively be switched to a reduced chemotherapy regimen, say researchers.

Ask the Experts

 

Columnists

Business of Medicine

  • The War Over MOC Heats Up In at least 17 states, doctors are battling the American Board of Medical Specialties, hospitals, and insurers in an effort to make maintenance of certification optional. Here's how it's going.
  • A Hospital Gets Sued for Keeping a Patient Alive   Hospital clinicians who don't follow a patient's advance healthcare directive are at risk of being sued.

Medscape Drugs & Diseases

  • Case: Wrist Pain Post Pregnancy? A 31-year-old woman presents with right wrist pain following delivery of her baby girl. The pain is particularly intense when she picks up her child. What's the diagnosis?
  • Renal Biopsy A survey by UNOS showed great disparities in practice across US transplant centers regarding timing and performance of surveillance kidney transplant biopsies for diagnosing subclinical graft rejection.

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape